LinkedIn

Search



Hot Topics


NY/NJ AETC Trainings On-Demand Resources (5-22-2015)

Posted May 22, 2015

NY/NJ AETC offers online continuing education accredited videos and monographs. On the On-Demand web site, you can watch NY/NJ AETC lectures, complete self studies modules, and earn continuing education credits all from the comfort of your office or home, on your own schedule. Courses and self studies are available for physicians, physician assistants, nurse practitioners, nurses, pharmacists, dentists, and oral health providers. All activities are free of charge.

Recordings Available. Simply click on the links below.

Pre-Exposure Prophylaxis for HIV Prevention
A forum for Health and Human Service Providers and Clinicians interested in prescribing PrEP.
Archived Recording Available (Live program date 5/1/15)

Hepatitis C/HIV Co-Infection Treatment Update
Archived Recording Available (Live broadcast date 4/22/15)

HIV Pre-Exposure & Post-Exposure Prophylaxis
Archived Recording Available (Live broadcast date 10/22/14)

Antiretroviral Treatment Update
Archived Recording Available (Live broadcast date on 4/9/14)

New York/New Jersey AIDS Education & Training Center
New York/New Jersey AETC Trainings On-Demand Online Courses
AETC National Resource Center

 

^ Return to Top


NYS Clinical Education: New Learning Modules (5-19-2015)

Posted May 19, 2015

New Learning Modules
The Clinical Education Initiative is pleased to announce the availability of two new learning modules. All modules are free and can be viewed online at any time.

Please visit http://www.ceitraining.org/resources/audio-video.cfm to view all of our learning modules.

For more information, please visit http://www.ceitraining.org/

 

^ Return to Top


WHO Issues Interim Advice on Sexual Transmission of Ebola (5/14/2015)

Posted May 14, 2015

With sexual contact emerging as a possible route of Ebola virus transmission, especially from men to women, the World Health Organization (WHO) has issued interim precautionary recommendations for sexually active survivors.

To view the WHO’s recommendations, please visit http://www.who.int/reproductivehealth/topics/rtis/ebola-virus-semen/en/.

 

^ Return to Top


Dear Colleague Letter: Summary of PrEP Studies Presented at CROI (5-12-2015)

Posted May 12, 2015

Dear Colleague,

The New York State Department of Health (NYSDOH) AIDS Institute supports the use of Pre-exposure Prophylaxis (PrEP) as a first line intervention for individuals at high risk of acquiring HIV. This biomedical prevention measure may prove to be the key in New York State’s effort to end the epidemic.

I invite you to read and share the attached letter written by Demetre Daskalakis, MD, MPH, Assistant Commissioner of the New York City Department of Health and Mental Hygiene. Dr. Daskalakis summarizes three recent studies on PrEP that were presented at the February 2015 Conference on Retroviruses and Opportunistic Infections (CROI). The results of the studies may raise some questions about the frequency of administration of PrEP and this letter assists with interpreting the findings and addressing patient concerns.

At this time, the NYSDOH Guidelines committee continues to recommend daily dosing of PrEP to protect against HIV.

We are committed to providing the tools clinicians need to feel confident when prescribing PrEP to their
patients.

To download the letter, please click here.

 

^ Return to Top


CDC Travel Advisory: Hepatitis A in Tulum, Mexico (5-12-2015)

Posted May 12, 2015

Summary

As of May 1, 2015, 27 cases of hepatitis A virus (HAV) infection were reported in individuals who traveled to Tulum, Mexico. Of those cases, 11 were reported in residents of New York City.

The CDC has issued a Level 1 Travel Advisory and recommends HAV vaccination for all previously unimmunized individuals who plan to travel to Tulum. The CDC also recommends that all people who have traveled to Tulum and returned within the last 2 weeks receive one dose of HAV vaccine, which can prevent or reduce the symptoms of HAV if administered within 14 days of exposure. Contraindications to HAV vaccine include history of reaction to the vaccine or vaccine components.

Click here to read the entire CDC travel advisory.

Click here for additional information about HAV infection and vaccination.

 

^ Return to Top


Ending the Epidemic Blueprint (5-1-2015)

Posted May 1, 2015

Ending the AIDS Epidemic in New York State

On June 29, 2014, Governor Andrew M. Cuomo detailed a three-point plan to end the AIDS epidemic in New York State. On October 14, 2014, members of the public were appointed to the Ending the Epidemic Task Force (Task Force). The Task Force was charged with advising the New York State Department of Health (Department) on strategies to achieve the goals outlined in the Governor’s plan. The plan aims to reduce new HIV infections and improve the health of all HIV-infected New Yorkers. This will be accomplished by identifying persons with HIV, linking and retaining persons diagnosed with HIV in health care, and facilitating access to Pre-Exposure Prophylaxis (PrEP) for high-risk persons to keep them HIV negative.

To view New York State’s Blueprint to End the AIDS Epidemic, please click here.

For more information, please visit https://www.health.ny.gov/diseases/aids/ending_the_epidemic/

For more information and to view a webcast of Governor Cuomo receiving the Ending the Epidemic Blueprint, please visit https://www.governor.ny.gov/news/governor-cuomo-receives-final-blueprint-end-hivaids-epidemic-new-york-state-end-2020

 

^ Return to Top


Medicaid Update: April (4-30-2015)

Posted April 30, 2015

Dear Medicaid Provider,

The Office of Health Insurance Programs of the New York State Department of Health has approved the release of the April 2015 Medicaid Update.

Please click the link below to download the current edition.
http://www.health.ny.gov/health_care/medicaid/program/update/2015/april_mu.pdf (PDF)

To see a list of all of the 2015 DOH Medicaid Updates, please visit http://www.health.ny.gov/health_care/medicaid/program/update/2015/index.htm

 

^ Return to Top


CDC Health Advisory: Outbreak of Recent HIV and HCV Infections among Persons Who Inject Drugs (4-24-2015)

Posted April 24, 2015

Summary

The Indiana State Department of Health (ISDH) and the Centers for Disease Control and Prevention (CDC) are investigating a large outbreak of recent human immunodeficiency virus (HIV) infections among persons who inject drugs (PWID). Many of the HIV-infected individuals in this outbreak are co-infected with hepatitis C virus (HCV). The purpose of this HAN Advisory is to alert public health departments and healthcare providers of the possibility of HIV outbreaks among PWID and to provide guidance to assist in the identification and prevention of such outbreaks.

Click here to read the entire official CDC Health Advisory.

Click here to read the CDC’s Morbidity and Mortality Weekly Report (MMWR).

 

^ Return to Top


Dear Medical Provider Letter: Post-Exposure Prophylaxis (PEP) to Prevent HIV Infection (4-9-2015)

Posted April 9, 2015

Dear Medical Provider:

Post-exposure prophylaxis (PEP) to prevent HIV infection is a proven, yet underutilized method of preventing new cases of HIV infection. This letter is written to disseminate the updated 2014 New York State Department of Health (NYSDOH) clinical guidelines and to encourage clinical providers across NYS to be vigilant in identifying cases where PEP may be prescribed to prevent HIV infection.

Exposure to HIV is a medical emergency. Given a brief window of opportunity, health care providers must act quickly to recommend and initiate PEP in cases where a patient has had a recent significant exposure that could lead to HIV infection. It is important to note that the current regimen used in PEP is more effective and better tolerated than previous regimens. Clinical providers should triage patients who may require PEP as urgent cases because PEP should ideally be initiated within two hours and no later than 36 hours after exposure. A best practice is to administer the first dose of PEP while conducting a baseline evaluation to establish that the patient: 1) is not already HIV-infected; and 2) has a high risk of exposure to HIV.

Below are links to the updated clinical guidelines for prescribing PEP and other resources available from the NYSDOH to support the provision of PEP:

To download the letter, please click here.

 

^ Return to Top


Email Announcement Archives

The HIV Clinical Guidelines Program provides subscribers with email announcements of when new guidelines are posted and existing guidelines are updated.

hivguidelines email announcement archives

Subscribe to hivguidelines email announcements

 

^ Return to Top


Hot Topics Archive

Please visit the Hot Topics Archive page.

^ Return to Top